Pathogenesis Of osteosclerotic change following anti-RANKL antibody (Denosumab) treatment for giant cell tumor of bone: Where does it come from?
Pathogenesis Of osteosclerotic change following anti-RANKL antibody (Denosumab) treatment for giant cell tumor of bone: Where does it come from?
复制标题
抗 RANKL 抗体（Denosumab）治疗骨巨细胞瘤后骨硬化变化的发病机制：它来自哪里？
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Tsuchiya H
中科院分区：
文献类型：
--
作者：
Takeuchi A;Rosario M;Yamamoto N;Hayashi K;Higuchi T;Abe K;Taniguchi Y;Aiba H;Murakami H;Tsuchiya H
